Cabozantinib | Cabozantinib : ATP Competitive inhibitor of KDR
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Control Compounds

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
KDR
  • IC50:0.035 nM
  • IC50:6.7 nM
  • IC50:4.1-7.7 nM
  • IC50:31 nM
  • IC50:9 nM
ATP Competitive
up to 10 uM

Selectivity

In Vitro Selectivity Assessment

Potency: IC50 - c-Met 1.3 nM, Ret 4 nM, Kit 4.6 nM, Flt-1/3/4 12 nM/11.3 nM/6 nM, Tie2 14.3 nM, AXL 7 nM

Potency Assay Off-Target:
AlphaScreen Assay, Coupled Luciferase Assay, Radiometric Assay
Selectivity Assessment Description:
The inhibition profile of cabozantinib against a broad panel of 270 human kinases was determined ...

Potency
Cellular
In Vitro

KDR

Mode of Action: ATP Competitive

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1158/1535-7163.MCT-11-0264

In Vivo Validations

Mouse
Dose: 100 mg/Kg
Route of delivery: Oral

DOI Reference: 10.1158/1535-7163.MCT-11-0264

Orthogonal Probes def

BRIVANIB

Chemical Information

Molecular Formula C28H24FN3O5
SMILEs COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC
InChI InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)
Molecular weight 501.17 Da
AlogP 5.5408
HBond acceptors 8
HBond donors 2
Atoms 61

References

Cross References

canSARChEMBLBindingDB

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


No SERP comments found for Cabozantinib

Probe Cabozantinib is in the process of SERP review.

Please continue to check back for new reviews and commentary.